BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20580715)

  • 1. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
    Nie J; Wu M; Wang J; Xing G; He F; Zhang L
    FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
    Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
    Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
    Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
    Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation.
    Nie J; Liu L; Wu M; Xing G; He S; Yin Y; Tian C; He F; Zhang L
    FEBS Lett; 2010 Jul; 584(14):3005-12. PubMed ID: 20621832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REGgamma: a shortcut to destruction.
    Zhou P
    Cell; 2006 Jan; 124(2):256-7. PubMed ID: 16439199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smurf1 targets Securin for ubiquitin-dependent degradation and regulates the metaphase-to-anaphase transition.
    Wei R; Li B; Guo J; Li M; Zhu R; Yang X; Gao R
    Cell Signal; 2017 Oct; 38():60-66. PubMed ID: 28658604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
    Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP
    Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome.
    Chen X; Barton LF; Chi Y; Clurman BE; Roberts JM
    Mol Cell; 2007 Jun; 26(6):843-52. PubMed ID: 17588519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Interaction Between Smurfl WW2 Domain and PPXY Motifs of Smadl, Smad5, and Smad6-Modeling and Analysis.
    Sangadala S; Rao Metpally RP; B Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 22670624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
    Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
    J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins.
    Guo R; Yamashita M; Zhang Q; Zhou Q; Chen D; Reynolds DG; Awad HA; Yanoso L; Zhao L; Schwarz EM; Zhang YE; Boyce BF; Xing L
    J Biol Chem; 2008 Aug; 283(34):23084-92. PubMed ID: 18567580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smurf1 directly targets hPEM-2, a GEF for Cdc42, via a novel combination of protein interaction modules in the ubiquitin-proteasome pathway.
    Yamaguchi K; Ohara O; Ando A; Nagase T
    Biol Chem; 2008 Apr; 389(4):405-13. PubMed ID: 18208356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells.
    Xie P; Tang Y; Shen S; Wang Y; Xing G; Yin Y; He F; Zhang L
    Biochem Biophys Res Commun; 2011 Apr; 407(1):254-9. PubMed ID: 21382345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
    Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D
    J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.
    Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F
    J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
    Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
    Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation.
    Wang Y; Nie J; Wang Y; Zhang L; Lu K; Xing G; Xie P; He F; Zhang L
    EMBO Rep; 2012 Nov; 13(11):1004-11. PubMed ID: 23032291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of c-Myc protein stability by proteasome activator REGγ.
    Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P
    Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.